文献速递细菌感染、耐药与抗菌药物

台湾无害梭菌感染的病例对照研究

Case-Control Study of Clostridium innocuum Infection, Taiwan.
PubMed 文献 · Emerg Infect Dis · 2022-01-01

在台湾2014-2019年开展病例对照研究,纳入152例无害梭菌感染患者,按诊断年份、年龄(±2岁)和性别匹配304例艰难梭菌感染对照。无害梭菌感染组肠外梭菌感染和胃肠道相关并发症多于对照组,30天死亡率为14.5%,总死亡率为23.0%。慢性肾病、实体瘤、重症监护病房入住和休克状态是4个独立死亡危险因素。

要点

  • 无害梭菌感染患者30天死亡率为14.5%,总死亡率为23.0%。
  • 慢性肾病、实体瘤、重症监护病房入住和休克状态是4个独立死亡危险因素。
  • 临床标本中检出的无害梭菌应被识别为需要治疗的病原体,因其固有万古霉素耐药,需精准鉴定以指导及时恰当的抗菌治疗。

核心结论

  • 临床标本中检出的无害梭菌应被识别为需要治疗的病原体,因其固有万古霉素耐药,精准鉴定对于指导恰当且及时的抗菌治疗是必要的。

研究设计与样本

  • 病例对照研究,纳入2014-2019年台湾152例无害梭菌感染患者,以304例按诊断年份、年龄(±2岁)和性别匹配的艰难梭菌感染(CDI)病例为对照。

主要发现

  • 两组基线特征相似。
  • 无害梭菌感染患者比CDI患者经历更多的肠外梭菌感染和胃肠道相关并发症。
  • 无害梭菌感染患者30天死亡率为14.5%,总死亡率为23.0%。
  • 慢性肾病、实体瘤、重症监护病房入住和休克状态是4个独立死亡危险因素。

临床怎么用

  • 临床标本中检出的无害梭菌应被识别为需要治疗的病原体,并因其固有万古霉素耐药而需精准鉴定以指导恰当且及时的抗菌治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Vancomycin-resistant Clostridium innocuum was recently identified as an etiologic agent for antibiotic-associated diarrhea in humans. We conducted a case-control study involving 152 C. innocuum-infected patients during 2014-2019 in Taiwan, using 304 cases of Clostridioides difficile infection (CDI) matched by diagnosis year, age (+2 years), and sex as controls. The baseline characteristics were similar between the 2 groups. C. innocuum-infected patients experienced more extraintestinal clostridial infection and gastrointestinal tract-related complications than did patients with CDI. The 30-day mortality rate among C. innocuum-infected patients was 14.5%, and the overall rate was 23.0%. Chronic kidney disease, solid tumor, intensive care unit admission, and shock status were 4 independent risk factors for death. C. innocuum identified from clinical specimens should be recognized as a pathogen requiring treatment, and because of its intrinsic vancomycin resistance, precise identification is necessary to guide appropriate and timely antimicrobial therapy.

来源:Emerg Infect Dis,查看原文。版权归原作者所有。

引用

  1. Chen YC, Kuo YC, Chen MC, et al. Case-Control Study of Clostridium innocuum Infection, Taiwan. Emerg Infect Dis. 2022. PMID: 35195517. doi:10.3201/eid2803.204421

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。